The new Medicare bill: far-reaching effects on cancer treatment.
Recent legislation has dramatically changed the Medicare payment methods for drugs and drug administration services. A large net reduction in total payments will take effect in 2005 and is likely to have significant adverse effects on the delivery of care to cancer patients.
Bailes
Joseph S
JS
Texas Oncology, Houston, USA.
Coleman
Terry
T
D000970:Antineoplastic Agents / Q000191:economics; D003695:Delivery of Health Care / Q000191:economics / Q000331:legislation & jurisprudence*; D016527:Drug Costs / Q000331:legislation & jurisprudence; D006801:Humans; D007342:Insurance Benefits / Q000331:legislation & jurisprudence; D019458:Insurance Coverage / Q000331:legislation & jurisprudence; D007356:Insurance, Pharmaceutical Services / Q000331:legislation & jurisprudence; D008495:Medical Oncology / Q000191:economics; D006278:Medicare / Q000331:legislation & jurisprudence*; D009369:Neoplasms / Q000191:economics / Q000628:therapy*; D009819:Office Visits / Q000191:economics; D010044:Outpatient Clinics, Hospital / Q000331:legislation & jurisprudence; D010045:Outpatients; D012051:Reimbursement Mechanisms / Q000331:legislation & jurisprudence; D014481:United States
D000970:Antineoplastic Agents